15-year experience on intravesical therapy of T1G3 urinary bladder cancer: a conservative approach.

@article{Cheng200415yearEO,
  title={15-year experience on intravesical therapy of T1G3 urinary bladder cancer: a conservative approach.},
  author={Chi Wai Cheng and Siu Foon Peter Chan and Lung Wai Chan and Chi Kwok Chan and Chi Ng and Ho Yuen Cheung and Shu Yin Eddie Chan and Wai Sang Wong and Fernand Mac-Moune Lai and Miu Ling Li},
  journal={Japanese journal of clinical oncology},
  year={2004},
  volume={34 4},
  pages={
          202-5
        }
}
  • Chi Wai Cheng, Siu Foon Peter Chan, +7 authors Miu Ling Li
  • Published in
    Japanese journal of clinical…
    2004
  • Medicine
  • OBJECTIVE To report the recurrence, progression and survival in patients with T1G3 transitional cell carcinoma (TCC) of the urinary bladder treated with sequential intravesical bacillus Calmette-Guérin (BCG) and chemotherapeutic agents (doxorubicin or epirubicin) on long-term follow up. METHODS Between July 1988 and September 1999, all patients in a single center with T1G3 bladder TCC, after complete transurethral resection (TURBT), received either 81 mg of Connaught strain BCG or 50 mg of… CONTINUE READING

    Create an AI-powered research feed to stay up to date with new papers like this posted to ArXiv

    Citations

    Publications citing this paper.
    SHOWING 1-10 OF 12 CITATIONS

    Results of Intravesical Chemo-Hyperthermia in High-risk Non-muscle Invasive Bladder Cancer.

    VIEW 2 EXCERPTS
    CITES BACKGROUND
    HIGHLY INFLUENCED

    The optimal management of T1 high-grade bladder cancer.

    Treatment Options for High-Risk T1 Bladder Cancer

    VIEW 2 EXCERPTS
    CITES RESULTS